Spine News and Research

RSS
Bone density related to duration of lactation

Bone density related to duration of lactation

Accuray announces installation of CyberKnife M6 and TomoTherapy Systems at FALP Cancer Institute in Chile

Accuray announces installation of CyberKnife M6 and TomoTherapy Systems at FALP Cancer Institute in Chile

Cerapedics' i-FACTOR Peptide Enhanced Bone Graft gets FDA approval for use in cervical spine surgery

Cerapedics' i-FACTOR Peptide Enhanced Bone Graft gets FDA approval for use in cervical spine surgery

Children's Memorial Hermann Hospital offers Halloween safety tips

Children's Memorial Hermann Hospital offers Halloween safety tips

Students introduced to da Vinci Robotic Surgical System at Saint Francis Memorial Hospital

Students introduced to da Vinci Robotic Surgical System at Saint Francis Memorial Hospital

Low-weight, high-repetition resistance training increases bone density in adults

Low-weight, high-repetition resistance training increases bone density in adults

CHMP recommends approval of Cosentyx in Europe to treat patients with AS and PsA, says Novartis

CHMP recommends approval of Cosentyx in Europe to treat patients with AS and PsA, says Novartis

Minimally invasive implant procedure effective for patients with sacroiliac joint dysfunction

Minimally invasive implant procedure effective for patients with sacroiliac joint dysfunction

Smartphone app may improve self-management skills in young patients with spina bifida

Smartphone app may improve self-management skills in young patients with spina bifida

Mordor Intelligence announces publication of ‘Global Sports Medicine Market’ report

Mordor Intelligence announces publication of ‘Global Sports Medicine Market’ report

Asterias’ Phase 1/2a study evaluates dose escalation of AST-OPC1 for cervical spinal cord injury

Asterias’ Phase 1/2a study evaluates dose escalation of AST-OPC1 for cervical spinal cord injury

TARSA Therapeutics' TBRIA NDA accepted by FDA for review

TARSA Therapeutics' TBRIA NDA accepted by FDA for review

UAMS researchers report positive results from treating Metastatic Merkel-cell carcinoma with idelalisib drug

UAMS researchers report positive results from treating Metastatic Merkel-cell carcinoma with idelalisib drug

University of Maryland develops GammaPod system to treat early-stage breast cancer

University of Maryland develops GammaPod system to treat early-stage breast cancer

UM SOM researchers to initiate first clinical trial of GammaPod system in patients with early-stage breast cancer

UM SOM researchers to initiate first clinical trial of GammaPod system in patients with early-stage breast cancer

Two-Level IDE approval granted to Simplify Medical’s cervical artificial disc

Two-Level IDE approval granted to Simplify Medical’s cervical artificial disc

LifeNet Health's ViviGen Cellular Bone Matrix wins Spine Technology Award

LifeNet Health's ViviGen Cellular Bone Matrix wins Spine Technology Award

Nanovis announces availability of new FortiCore interbody fusion devices

Nanovis announces availability of new FortiCore interbody fusion devices

Amedica launches innovative articulating inserter for minimally invasive TLIF procedures

Amedica launches innovative articulating inserter for minimally invasive TLIF procedures

The Medical Center of Plano Partners with BIND, Brain Injury Network of Dallas to support survivors of traumatic brain injuries

The Medical Center of Plano Partners with BIND, Brain Injury Network of Dallas to support survivors of traumatic brain injuries

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.